MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Clinical features"

  • 2019 International Congress

    Combined Botulinum Toxin and Gpi DBS therapy in intractable cervical dystonia

    AM. Macerollo, BH. Hammersley, ME. Esposito, JS. Somerset, RE. Ellis, MB. Bonello, JP. Panicker, DD. Damodoran, JOF. Farah, PE. Eldridge, SA. Alusi (Naples, Italy)

    Objective: To test whether the reintroduction of Botulinum Toxin Injections (BTI) after Globus pallidus interna Deep Brain Stimulation (Gpi-DBS) for intractable cervical dystonia synergistically improves…
  • 2019 International Congress

    Cerebellar brain inhibition and cervical dystonia: exploring clinico-electrophysiological associations

    R. Sondergaard, LS. Gan, Y. Jasaui, J. Sarna, S. Furtado, T. Pringsheim, D. Martino (Calgary, AB, Canada)

    Objective: To examine the association between clinical features of cervical dystonia (CD) and cerebellar inhibition of the motor cortex (M1). Background: The involvement of cerebellar…
  • 2019 International Congress

    Pantothenate kinase-associated neurodegeneration in Tunisian families

    H. Benrhouma, I. Kraoua, H. Klaa, A. Rouissi, EM. Valente, I. Benyoussef Turki (Tunis, Tunisia)

    Objective: To describe clinical features, imaging and genetic findings of 6 Tunisian families diagnosed with PKAN. Background: Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive…
  • 2019 International Congress

    The impact of physical activity and exercise on people living with dystonia

    L. Bradnam, R. Meiring, A. Mccambridge (Auckland, New Zealand)

    Objective: The objective was to conduct a survey to elucidate the impact of exercise and physical activity on dystonia and identify barriers to participation. Background:…
  • 2019 International Congress

    Domain-specific impact of mood/anxiety disorders on quality of life in idiopathic dystonia

    D. Martino, Y. Jasaui, J. Sarna, S. Furtado, S. Patten, T. Pringsheim (Calgary, AB, Canada)

    Objective: To evaluate the relationship between mood/anxiety disorder severity and quality of life (QoL) domains in adult-onset idiopathic dystonia (AOID). Background: Depression and anxiety exert…
  • 2019 International Congress

    Physiotherapy in cervical dystonia with focus on clinical assessments on ICF

    M. Steinboeck, H. Unger (Bad Aibling, Germany)

    Objective: It is to assess if the results of the common clinical evaluation of patients with cervical dystonia can be summarized in an objective observation…
  • 2019 International Congress

    Pre-status and status dystonicus in children and adolescents

    G. Garone, F. Graziola, F. Nicita, F. Frascarelli, F. Randi, M. Zazza, L. Cantonetti, F. Vigevano, CE. Marras, A. Capuano (Rome, Italy)

    Objective: Retrospective analysis of an 8-years' experience in diagnosis, management and follow-up of children experiencing Status dystonicus (SD) and pre-SD. Background: SD is considered the most…
  • 2019 International Congress

    Touching Nose: Alleviating Maneuvers (Sensory Tricks) in Orofacial Dystonia

    NG. Bülbül, MG. şenol (Istanbul, Turkey)

    Objective: Orofacial dystony is a type of focal dystonia that affects the facial and masticatory, cervical, laryngeal, eyelid, and pharyngeal muscles. Background: We present a…
  • 2019 International Congress

    Comparison of motor and non-motor symptoms in operated and medically treated dystonia patients

    A. Maurer, U. Hidding, W. Hamel, C. Moll, C. Gerloff, M. Gelderblom, S. Zittel-Dirks (Hamburg, Germany)

    Objective: To evaluate motor and psychiatric symptoms as well as quality of life (QoL) in dystonia patients treated with botulinumtoxin/medication (non-DBS group) and deep brain…
  • 2019 International Congress

    Musician’s dystonia: results from a large US case series

    C. Stephen, M. Charness (Boston, MA, USA)

    Objective: We describe the clinical characteristics of a large US cohort of musician’s focal dystonia (MFD), including both amateur and professional musicians. Background: Musician’s focal…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 48
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley